Skip to main content
L

Not yet reviewed: this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Citicoline

Citicoline molecule structureCiticoline molecule structure
Cytidine 5'-diphosphocholine
CDP-choline, Cytidine diphosphate cholineOpen in Piru
Psychoactive Class
Chemical Class

Citicoline is a water-soluble nootropic and naturally occurring ammonium salt nucleotide found in human and animal cells. Its structure links a cytidine nucleoside to choline through a diphosphate bridge, serving as an intermediate in phosphatidylcholine synthesis1. Supplementation provides choline and cytidine precursors1 and may support memory or attention, although some attention findings require replication. In healthy volunteers receiving citicoline at 600 or 1000 mg/day or placebo, no abnormal side effects were reported in hematological or clinical analyses1.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold50 mg
Light100-250 mg
Moderate250-1000 mg
Strong1000-2000 mg
Heavy2000+ mg
Bioavailability
98%

Duration

Onset1-2 hours
Come Up2-3 hours
Peak2.5-3.5 hours
Offset30-40 hours
After Effects40-60 hours
Total58-74 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacodynamics

Citicoline is an intermediate and choline donor in phosphatidylcholine biosynthesis. After hydrolysis, citicoline provides choline for acetylcholine synthesis; studies in transient cerebral ischemia suggest that it might enhance phosphatidylcholine synthesis, preserve cardiolipin and sphingomyelin, and stimulate glutathione synthesis and glutathione reductase activity, with the observed effects potentially explained by attenuation of phospholipase A2 activation2. It may also lower ischemia-induced glutamate concentrations and increase EAAT2-mediated glutamate uptake, which may reduce excitotoxic signaling. Choline-derived activity at nicotinic acetylcholine receptors has been proposed to contribute to dose-dependent analgesic effects.

Pharmacokinetics

Citicoline is hydrolyzed in the intestinal wall into choline and cytidine; after absorption, these cross the blood-brain barrier for re-synthesis into citicoline in the brain3. Citicoline is water-soluble with greater than 90% bioavailability; pharmacokinetic studies in healthy adults describe rapid absorption after oral dosing and biphasic plasma peaks at one hour and a second, larger peak at 24 hours after ingestion3. Pharmacokinetic studies using carbon-14-labelled citicoline show elimination mainly through respiratory carbon dioxide and urinary excretion in two phases3. Reported elimination half-lives are 56 hours for respiratory carbon dioxide and 71 hours for urinary excretion in pharmacokinetic studies using carbon-14-labelled citicoline3, and its concentration profile does not follow a single smooth exponential decline3.

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.

Full Tolerance
Citicoline does not seem to produce immediate tolerance; with prolonged use, its effects may become stronger, attributed to its long half-life. Use for periods longer than two weeks is not recommended.

Harm Potential

Addiction & Dependence

Psychological

Extremely Low

Citicoline is not considered habit-forming; interest in repeated use may lessen over time, making use generally self-limiting.

Physical

Extremely Low

Citicoline does not produce physical dependence.

Toxicity

Gastrointestinal

At therapeutic doses, short-lived mild adverse effects are uncommon; when they occur, stomach pain and diarrhea are among the most typical.

Psychosis Risk

Citicoline may exacerbate psychotic episodes in susceptible individuals. A 2020 meta-analysis did not support the hypothesis that chronic citicoline use causes adverse psychiatric effects, though concerns had been raised.

History & Culture

Citicoline has been investigated as a treatment, supportive-care agent, or diagnostic aid for conditions including mania, hypomania, bipolar disorder, stroke, and cocaine abuse. Research has also examined its use in cognitive impairment associated with stroke, vascular dementia, Alzheimer’s…

Legality

International

Approved, investigational, and withdrawn regulatory listings are reported without a country-specific status.

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed: this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Citicoline article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.